<DOC>
	<DOCNO>NCT01483326</DOCNO>
	<brief_summary>This observational study evaluate long-term efficacy safety RoActemra/Actemra ( tocilizumab participant ACT SURE clinical trial patient moderate severe rheumatoid arthritis start receive RoActemra/Actemra . Data collect patient 4 year .</brief_summary>
	<brief_title>An Observational Study Long-Term Efficacy Safety RoActemra/Actemra ( Tocilizumab ) Patients With Moderate Severe Rheumatoid Arthritis ( FAct )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Adult patient , &gt; 18 year age Participants ACTSURE trial , patient moderate severe rheumatoid arthritis start receive RoActemra/Actemra Contraindications RoActemra/Actemra</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>